Point-of-Care Diagnostics Market Size, Share, Trends, Growth Drivers, Development Facts and Figures by 2028
How big is the point-of-care diagnostics market?
The global point-of-care diagnostics market size reached US$ 45.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.96% during 2023-2028.
 |
| Point-of-Care Diagnostics Market Report 2023-2028 |
Industry Overview of Point-of-Care Diagnostics Market:
Point-of-care (POC) diagnostics refers to the medical diagnostic testing performed at or near the location where the patient is receiving care. Unlike traditional laboratory testing, which requires samples to be sent to a central lab, POC diagnostics provides immediate results at the bedside, doctor's office, home, or other care settings. POC diagnostics offers rapid results, often within minutes. This quick turnaround time is critical in acute or emergency situations, where immediate decision-making can affect patient outcomes. By enabling testing outside traditional laboratory settings, POC diagnostics brings essential diagnostic services to remote and underserved areas, enhancing healthcare equity. The immediacy of POC testing facilitates integrated care. Healthcare providers can make real-time decisions regarding diagnosis, treatment, and monitoring, often during a single patient visit.
Many POC diagnostic devices are designed to be user-friendly, allowing non-laboratory staff or even patients themselves to perform the tests. This has expanded the use of diagnostics to home care settings and has become particularly significant in managing chronic conditions. While POC tests may be more expensive on a per-test basis, they can lead to cost savings through faster decision-making, reduced hospital stays, and prevention of complications. Ensuring the accuracy and reliability of POC testing is a critical concern. Proper training, quality assurance processes, and regulatory compliance are essential to maintain standards comparable to central laboratory testing.
Request to Get the Sample Report: https://www.imarcgroup.com/point-of-care-diagnostics-market/requestsample
POC Diagnostics Market Drivers and Trends:
The evolution of technology is leading to the development of user-friendly, accurate, and portable POC devices represents one of the key factors driving the growth of the market across the globe. Innovations in miniaturization, connectivity, and automation continue to expand the capabilities of POC diagnostics. In emergency and acute care settings, timely diagnosis is crucial. The ability of POC diagnostics to provide immediate results is a significant driver in these scenarios. The rising prevalence of chronic conditions, such as diabetes and cardiovascular diseases requires regular monitoring.
POC diagnostics offers convenient monitoring and management tools, which is fueling the market growth. There's a growing trend towards decentralized healthcare, which is shifting from hospital-centric to community-based and home care. POC diagnostics aligns with this trend, offering flexible testing locations. The market is also driven by governments and international organizations which are increasingly supporting the deployment of POC diagnostics, especially in rural and underserved areas, through funding, regulations, and awareness campaigns. POC diagnostics empower patients with immediate insights into their health conditions. This alignment with patient-centered care philosophies is acting as a major growth-inducing factor.
An increase in the aging population brings a rise in healthcare needs, including regular monitoring and screening. POC diagnostics caters to this demand by offering accessible testing solutions. Regulatory authorities' efforts to ensure the quality and accuracy of POC diagnostics build trust among healthcare providers and patients, encouraging market adoption.
Continued efforts to educate healthcare professionals and the public about the benefits and proper usage of POC diagnostics are vital to the market growth. The seamless integration of POC diagnostics with electronic health records and telemedicine platforms is creating a positive outlook for the market across the globe.
Competitive Landscape with Key Players:
Key Companies:
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Hoffmann-La Roche AG
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- Pts Diagnostics
- Qiagen
- Siemens
- Trinity Biotech
Market Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Breakup by Platform:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Breakup by Prescription Mode:
- Prescription-Based Testing
- OTC Testing
Breakup by End-User:
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Speak to Analyst: https://www.imarcgroup.com/request?type=report&id=2113&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696
